Processa Pharmaceuticals

-$0.08 (-4.23%) As of 2:09 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PCSA and other ETFs, options, and stocks.

About PCSA

Processa Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of drug products for the treatment of serious medical conditions. Its main product candidate is PCS499, which is intended for the treatment of Necrobiosis Lipoidica.

CEO
David Young
Employees
15
Headquarters
Hanover, Maryland
Founded
2011

PCSA Key Statistics

Market cap
28.67M
Price-Earnings ratio
—
Dividend yield
—
Average volume
58.75K
High today
$1.81
Low today
$1.81
Open price
$1.81
Volume
750.00
52 Week high
$8.99
52 Week low
$1.50

PCSA Earnings

-$1.70
-$1.17
-$0.63
-$0.10
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.21 per share
Actual
-$0.20 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure